Blueprint Medicines Corp
NASDAQ:BPMC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Blueprint Medicines Corp
NASDAQ:BPMC
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BPMC's stock price target?
Not Available
BPMC doesn't have any price targets made by Wall Street professionals.
What is Blueprint Medicines Corp's Revenue forecast?
Projected CAGR
34%
The
compound annual growth rate
of
Blueprint Medicines Corp's revenue for the next 3 years is
34%.